Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats
Journal of Food Biochemistry · 2026-01 · 2026 (1)
DOI: 10.1155/jfbc/5511502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Biochemistry, online erschienen am 19.05.2026. Verfasst von Amal S. Abu-Almakarem und 9 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Green coffee bean extract (GCBE) has shown potential for antioxidants and anti‐inflammation due to its rich composition of bioactive compounds and polyphenols that possess neuroprotective properties, which have been suggested to counteract neurodegenerative processes associated with Alzheimer’s disease (AD). This study investigated the effect of GCBE treatment on aluminum chloride (AlCl 3 )‐induced AD in male rats. The pharmacokinetic properties of GCBE bioactive compounds were analyzed using the ADMET Lab 2.0 web servers, and molecular docking studies were performed using AutoDock Vina. Forty male Sprague–Dawley rats were divided into four equal groups; Group I was the negative control group; Group II received 250 mg/kg of GCBE (1/10 of LD 50 ) from the 25 th day to the 36 th day; Group III was given AlCl 3 (175 mg/kg) orally for 25 days, and Group IV was administered AlCl 3 for 25 days, like in Group III, and then treated with GCBE as in Group II. The results indicated that GCBE demonstrated promising phytochemical constituents with safe pharmacokinetic profiles. The LD 50 of GCBE was 2500 mg/kg b. wt. Behavioral assessments revealed significant improvement in cognitive performance in GCBE‐treated rats compared with the untreated AD group. Biochemical analyses demonstrated that GCBE significantly reduced oxidative stress and inflammatory markers. Moreover, GCBE markedly upregulated the expression of protein kinase (Akt1), cAMP‐response element binding protein (CREB), and brain‐derived neurotrophic factor (BDNF) indicating activation of neuroprotective signaling pathways. Histopathological examination further confirmed the protective effects of GCBE on hippocampal neuronal integrity. These findings suggest that GCBE exerted significant neuroprotective effects against AD, potentially through upregulation of the Akt/CREB/BDNF pathway, highlighting its potential as a promising therapeutic strategy for neurodegenerative disorders.
Zitieren
APA
Abu-Almakarem, A. S., Alzahrani, O. R., Abu-Khudir, R., Alassar, S. R., El-Said, K. S., Alkhodair, S. A., Banjabi, A. A., Al-Bazi, M. M., Mobasher, M. A., & Soliman, M. M. (2026). Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats. Journal of Food Biochemistry, 2026(1). https://doi.org/10.1155/jfbc/5511502
Vancouver
Abu-Almakarem AS, Alzahrani OR, Abu-Khudir R, Alassar SR, El-Said KS, Alkhodair SA, et al. Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats. Journal of Food Biochemistry. 2026;2026(1). doi:10.1155/jfbc/5511502
BibTeX
@article{AbuAlmakarem2026,
author = {Abu-Almakarem, Amal S. and Alzahrani, Othman R. and Abu-Khudir, Rasha and Alassar, S. R. and El-Said, Karim Samy and Alkhodair, Sahar Abdulrahman and Banjabi, Abeer A. and Al-Bazi, Maha M. and Mobasher, Maysa A. and Soliman, Mohamed Mostafa},
title = {Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats},
journal = {Journal of Food Biochemistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jfbc/5511502}
}
EUVIMED